Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Healthtrust
Chinese Patent Office
Express Scripts
Fish and Richardson
Cerilliant
US Department of Justice
Federal Trade Commission
Johnson and Johnson
Daiichi Sankyo

Generated: February 20, 2018

DrugPatentWatch Database Preview

Irbesartan - Generic Drug Details

« Back to Dashboard

What are the generic sources for irbesartan and what is the scope of irbesartan freedom to operate?

Irbesartan
is the generic ingredient in two branded drugs marketed by Sanofi Aventis Us, Ajanta Pharma Ltd, Alembic Pharms Ltd, Apotex Inc, Aurobindo Pharma Ltd, Cipla Ltd, Dr Reddys Labs Ltd, Hetero Labs Ltd V, Hisun Pharm Hangzhou, Jubilant Generics, Lupin Ltd, Macleods Pharms Ltd, Mylan Pharms Inc, Prinston Inc, Sandoz, Sciegen Pharms Inc, Teva Pharms, Unichem Labs Ltd, Watson Labs Inc, West-ward Pharms Int, and Zydus Pharms Usa Inc, and is included in twenty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-eight drug master file entries for irbesartan. Twenty-six suppliers are listed for this compound. There are three tentative approvals for this compound.
Pharmacology for irbesartan
Tentative approvals for IRBESARTAN
Applicant Application No. Strength Dosage Form
➤ Try a Free Trial➤ Try a Free Trial150MG; 12.5MGTABLET; ORAL
➤ Try a Free Trial➤ Try a Free Trial300MG; 25MGTABLET; ORAL
➤ Try a Free Trial➤ Try a Free Trial300MG; 12.5MGTABLET; ORAL

US Patents and Regulatory Information for irbesartan

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hisun Pharm Hangzhou IRBESARTAN irbesartan TABLET;ORAL 206194-003 Jun 14, 2016 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sciegen Pharms Inc IRBESARTAN irbesartan TABLET;ORAL 204774-002 Dec 7, 2015 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Alembic Pharms Ltd IRBESARTAN irbesartan TABLET;ORAL 091236-001 Oct 15, 2012 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sciegen Pharms Inc IRBESARTAN irbesartan TABLET;ORAL 204774-003 Dec 7, 2015 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Unichem Labs Ltd IRBESARTAN irbesartan TABLET;ORAL 203020-003 Dec 7, 2015 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Ajanta Pharma Ltd IRBESARTAN irbesartan TABLET;ORAL 203685-003 Dec 10, 2015 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Pharms Inc IRBESARTAN irbesartan TABLET;ORAL 200461-002 Sep 27, 2012 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Apotex Inc IRBESARTAN irbesartan TABLET;ORAL 200832-003 Oct 15, 2012 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Teva Pharms IRBESARTAN irbesartan TABLET;ORAL 077159-001 Mar 30, 2012 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Macleods Pharms Ltd IRBESARTAN irbesartan TABLET;ORAL 202254-003 Oct 3, 2012 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for irbesartan

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us AVAPRO irbesartan TABLET;ORAL 020757-001 Sep 30, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Sanofi Aventis Us AVAPRO irbesartan TABLET;ORAL 020757-002 Sep 30, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Sanofi Aventis Us AVAPRO irbesartan TABLET;ORAL 020757-003 Sep 30, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Sanofi Aventis Us AVAPRO irbesartan TABLET;ORAL 020757-003 Sep 30, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Sanofi Aventis Us AVAPRO irbesartan TABLET;ORAL 020757-001 Sep 30, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Sanofi Aventis Us AVAPRO irbesartan TABLET;ORAL 020757-002 Sep 30, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Dow
Mallinckrodt
Healthtrust
UBS
Teva
Argus Health
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot